Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K.
Endocr Rev. 2022 Mar 9;43(2):199-239. doi: 10.1210/endrev/bnab019.
Paraganglioma of the Head and Neck: A Review.
Sandow L, Thawani R, Kim MS, Heinrich MC.
Endocr Pract. 2023 Feb;29(2):141-147. doi: 10.1016/j.eprac.2022.10.002. Epub 2022 Oct 15.
The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
Lima JV Júnior, Kater CE.
Int Braz J Urol. 2023 May-Jun;49(3):307-319. doi: 10.1590/S1677-5538.IBJU.2023.0038.
Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
Jain A, Baracco R, Kapur G.
Pediatr Nephrol. 2020 Apr;35(4):581-594. doi: 10.1007/s00467-018-4181-2. Epub 2019 Jan 2.
Phaeochromocytoma and Paraganglioma.
Gunawardane PTK, Grossman A.
Adv Exp Med Biol. 2017;956:239-259. doi: 10.1007/5584_2016_76.
Cardiac paraganglioma.
El-Ashry AA, Cerfolio RJ, Singh SP, McGiffin D.
J Card Surg. 2015 Feb;30(2):135-9. doi: 10.1111/jocs.12479. Epub 2014 Dec 22.
Sporadic paraganglioma.
Lee JA, Duh QY.
World J Surg. 2008 May;32(5):683-7. doi: 10.1007/s00268-007-9360-4.
Antiangiogenic therapies for pheochromocytoma and paraganglioma.
Jimenez C, Fazeli S, Román-Gonzalez A.
Endocr Relat Cancer. 2020 Jul;27(7):R239-R254. doi: 10.1530/ERC-20-0043.
Pheochromocytoma and paraganglioma in children and adolescents.
Stachowicz-Stencel T, Pasikowska N, Synakiewicz A.
Acta Biochim Pol. 2023 Sep 17;70(3):487-493. doi: 10.18388/abp.2020_6955.
Addressing delays in the diagnosis of pheochromocytoma/paraganglioma.
Ilias I, Thomopoulos C.
Expert Rev Endocrinol Metab. 2019 Sep;14(5):359-363. doi: 10.1080/17446651.2019.1657007. Epub 2019 Aug 20.
